2011
DOI: 10.1007/s11606-010-1629-x
|View full text |Cite
|
Sign up to set email alerts
|

Examining the Evidence: A Systematic Review of the Inclusion and Analysis of Older Adults in Randomized Controlled Trials

Abstract: Clinical trial evidence guiding treatment of complex, older adults could be improved by eliminating upper age limits for study inclusion, by reducing the use of eligibility criteria that disproportionately affect multimorbid older patients, by evaluating outcomes that are highly relevant to older individuals, and by encouraging adherence to recommended analytic methods for evaluating differential treatment effects by age.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
238
1
5

Year Published

2012
2012
2020
2020

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 325 publications
(246 citation statements)
references
References 33 publications
2
238
1
5
Order By: Relevance
“…28 The treatment of breast cancer in older patients is still not evidence-based because older patients are often not included in clinical trials on account of restrictions of age, comorbidities, and physical function. 29 This leads to a large diversity of treatment strategies and poor adherence to guidelines among treating specialists. 30 Consequently, breast cancer-specific mortality increases with age, even amid competing causes of death in older patients.…”
Section: Discussionmentioning
confidence: 99%
“…28 The treatment of breast cancer in older patients is still not evidence-based because older patients are often not included in clinical trials on account of restrictions of age, comorbidities, and physical function. 29 This leads to a large diversity of treatment strategies and poor adherence to guidelines among treating specialists. 30 Consequently, breast cancer-specific mortality increases with age, even amid competing causes of death in older patients.…”
Section: Discussionmentioning
confidence: 99%
“…This will require that clinical effectiveness studies include, or even oversample, patients with comorbidities, and researchers examine potential differential treatment effects by comorbidity type and overall health status. 69,70 There is also an opportunity to enhance clinical care for multimorbid patients by encouraging discussions about how patients' comorbidities interact and affect their self-management practices and overall well-being. For example, patients with multiple conditions may more readily accommodate a new treatment if their provider encourages them to link it to their care for a comorbid condition.…”
Section: Research and Clinical Carementioning
confidence: 99%
“…In keeping with previous research suggesting that randomised studies seldom include older patients [28], the group acknowledged that the strength of the evidence base for providing practice recommendation in this group of patients is sometimes limited. Some of the topics (see Table A) will therefore be addressed as 'pro-con debates' between experts (for example, dialysis modality selection [29] and optimising dialysis adequacy [30]).…”
Section: Future Stepsmentioning
confidence: 81%